| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.929 | 0.002 | 0.929 | Caspase 9 stimulant | 0.924 0.002 CID_154699992 | ||
| 0.902 | 0.001 | 0.902 | Cystathionine beta-synthase inhibitor | 0.87 0.001 CID_154699992 | ||
| 0.881 | 0.004 | 0.881 | 12-Lipoxygenase inhibitor | 0.235 0.118 CID_154699992 | ||
| 0.873 | 0.003 | 0.873 | Free radical scavenger | 0.864 0.004 CID_154699992 | ||
| 0.866 | 0.004 | 0.866 | Aldehyde oxidase inhibitor | 0.204 0.102 CID_154699992 | ||
| 0.864 | 0.009 | 0.864 | Apoptosis agonist | 0.854 0.01 CID_154699992 | ||
| 0.857 | 0.004 | 0.888 | Antioxidant | 0.888 0.004 CID_154699992 | CID_154699992 | |
| 0.792 | 0.007 | 0.792 | 15-Lipoxygenase inhibitor | |||
| 0.802 | 0.018 | 0.948 | Alpha-glucosidase inhibitor | 0.948 0.005 CID_154699992 | CID_154699992 | |
| 0.783 | 0.004 | 0.783 | Caspase 3 stimulant | 0.692 0.006 CID_154699992 | ||
| 0.779 | 0.002 | 0.779 | Peroxidase inhibitor | 0.302 0.037 CID_154699992 | ||
| 0.76 | 0.005 | 0.76 | Amyloid beta aggregation inhibitor | 0.555 0.01 CID_154699992 | ||
| 0.759 | 0.004 | 0.759 | Lipoxygenase inhibitor | 0.279 0.082 CID_154699992 | ||
| 0.748 | 0.002 | 0.913 | Xanthine oxidase inhibitor | 0.913 0.002 CID_154699992 | CID_154699992 | |
| 0.74 | 0.004 | 0.957 | Monophenol monooxygenase inhibitor | 0.957 0.002 CID_154699992 | CID_154699992 | |
| 0.75 | 0.016 | 0.922 | Transcription factor NF kappa B inhibitor | 0.922 0.004 CID_154699992 | CID_154699992 | |
| 0.738 | 0.008 | 0.738 | Aryl hydrocarbon receptor agonist | 0.286 0.065 CID_154699992 | ||
| 0.734 | 0.004 | 0.734 | Superoxide dismutase inhibitor | 0.197 0.12 CID_154699992 | ||
| 0.727 | 0.002 | 0.727 | NADPH oxidase inhibitor | 0.694 0.003 CID_154699992 | ||
| 0.727 | 0.003 | 0.727 | Breast cancer-resistant protein inhibitor | 0.208 0.013 CID_154699992 | ||
| 0.718 | 0.002 | 0.76 | Carbonic anhydrase XIII inhibitor | 0.76 0.002 CID_154699992 | CID_154699992 | |
| 0.7 | 0.005 | 0.816 | Histamine release inhibitor | 0.816 0.003 CID_154699992 | CID_154699992 | |
| 0.697 | 0.004 | 0.697 | MAO A inhibitor | 0.105 0.061 CID_154699992 | ||
| 0.652 | 0.004 | 0.829 | Amylase inhibitor | 0.829 0.001 CID_154699992 | CID_154699992 | |
| 0.653 | 0.005 | 0.653 | MAO inhibitor | |||
| 0.639 | 0.005 | 0.639 | GABA C receptor rho-3 antagonist | |||
| 0.663 | 0.038 | 0.832 | Antiinflammatory | 0.832 0.011 CID_154699992 | CID_154699992 | |
| 0.611 | 0.005 | 0.611 | P-glycoprotein inhibitor | 0.477 0.01 CID_154699992 | ||
| 0.607 | 0.008 | 0.646 | DNA damaging | 0.646 0.006 CID_154699992 | CID_154699992 | |
| 0.597 | 0.002 | 0.597 | Creatine kinase inhibitor | 0.212 0.009 CID_154699992 | ||
| 0.596 | 0.003 | 0.596 | Carbonic anhydrase III inhibitor | 0.392 0.004 CID_154699992 | ||
| 0.6 | 0.008 | 0.653 | Hypoxia-inducible factor 1 alpha inhibitor | 0.653 0.005 CID_154699992 | CID_154699992 | |
| 0.583 | 0.004 | 0.583 | Interleukin 4 antagonist | 0.389 0.005 CID_154699992 | ||
| 0.587 | 0.009 | 0.688 | Antiamyloidogenic | 0.688 0.005 CID_154699992 | CID_154699992 | |
| 0.581 | 0.004 | 0.795 | Melanin inhibitor | 0.795 0.002 CID_154699992 | CID_154699992 | |
| 0.581 | 0.009 | 0.834 | Vasodilator, coronary | 0.834 0.003 CID_154699992 | CID_154699992 | |
| 0.573 | 0.016 | 0.674 | Spasmolytic | 0.674 0.007 CID_154699992 | CID_154699992 | |
| 0.559 | 0.006 | 0.559 | Tubulin antagonist | 0.23 0.029 CID_154699992 | ||
| 0.557 | 0.014 | 0.622 | Apoptosis antagonist | 0.622 0.008 CID_154699992 | CID_154699992 | |
| 0.545 | 0.004 | 0.574 | Alkaline phosphatase inhibitor | 0.574 0.004 CID_154699992 | CID_154699992 | |
| 0.544 | 0.005 | 0.559 | NOS3 expression enhancer | 0.559 0.004 CID_154699992 | CID_154699992 | |
| 0.548 | 0.013 | 0.646 | Nitric oxide antagonist | 0.646 0.008 CID_154699992 | CID_154699992 | |
| 0.55 | 0.019 | 0.606 | 5 Hydroxytryptamine release inhibitor | 0.606 0.01 CID_154699992 | CID_154699992 | |
| 0.54 | 0.011 | 0.625 | Tumour necrosis factor alpha release inhibitor | 0.625 0.006 CID_154699992 | CID_154699992 | |
| 0.526 | 0.003 | 0.526 | Carbonic anhydrase VI inhibitor | 0.313 0.005 CID_154699992 | ||
| 0.518 | 0.004 | 0.644 | DNA methyltransferase I inhibitor | 0.644 0.003 CID_154699992 | CID_154699992 | |
| 0.515 | 0.008 | 0.515 | Pyruvate kinase inhibitor | 0.207 0.077 CID_154699992 | ||
| 0.504 | 0.004 | 0.504 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.436 0.006 CID_154699992 | ||
| 0.505 | 0.006 | 0.511 | Topoisomerase II inhibitor | 0.511 0.006 CID_154699992 | CID_154699992 | |
| 0.502 | 0.012 | 0.53 | Vasodilator | 0.53 0.01 CID_154699992 | CID_154699992 | |
| 0.499 | 0.011 | 0.499 | RNA-directed DNA polymerase inhibitor | 0.451 0.014 CID_154699992 | ||
| 0.488 | 0.002 | 0.491 | Nitric-oxide synthase stimulant | 0.491 0.002 CID_154699992 | CID_154699992 | |
| 0.488 | 0.002 | 0.488 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.149 0.019 CID_154699992 | ||
| 0.488 | 0.005 | 0.509 | Lipid peroxidase inhibitor | 0.509 0.005 CID_154699992 | CID_154699992 | |
| 0.519 | 0.038 | 0.519 | Prostaglandin dehydrogenase inhibitor | |||
| 0.492 | 0.016 | 0.725 | Hypoglycemic | 0.725 0.005 CID_154699992 | CID_154699992 | |
| 0.468 | 0.009 | 0.638 | Hepatoprotectant | 0.638 0.004 CID_154699992 | CID_154699992 | |
| 0.466 | 0.007 | 0.621 | DNA methylase inhibitor | 0.621 0.004 CID_154699992 | CID_154699992 | |
| 0.46 | 0.004 | 0.83 | Beta glucuronidase inhibitor | 0.83 0.001 CID_154699992 | CID_154699992 | |
| 0.477 | 0.023 | 0.477 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.457 | 0.005 | 0.584 | Protein kinase stimulant | 0.584 0.003 CID_154699992 | CID_154699992 | |
| 0.45 | 0.007 | 0.45 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.142 CID_154699992 | ||
| 0.445 | 0.004 | 0.445 | Topoisomerase II alpha inhibitor | 0.415 0.004 CID_154699992 | ||
| 0.43 | 0.005 | 0.43 | Acetylcholinesterase inhibitor | 0.177 0.041 CID_154699992 | ||
| 0.468 | 0.05 | 0.718 | Antibacterial | 0.718 0.007 CID_154699992 | CID_154699992 | |
| 0.414 | 0.002 | 0.414 | Xanthine dehydrogenase inhibitor | 0.229 0.004 CID_154699992 | ||
| 0.43 | 0.019 | 0.43 | Antimitotic | 0.275 0.051 CID_154699992 | ||
| 0.413 | 0.003 | 0.413 | GABA C receptor rho-2 antagonist | |||
| 0.412 | 0.013 | 0.412 | Dual specificity phosphatase inhibitor | 0.149 0.095 CID_154699992 | ||
| 0.399 | 0.007 | 0.399 | MAO B inhibitor | |||
| 0.391 | 0.005 | 0.391 | 5-Lipoxygenase inhibitor | 0.101 0.063 CID_154699992 | ||
| 0.389 | 0.004 | 0.389 | Carbonic anhydrase XV inhibitor | 0.091 0.081 CID_154699992 | ||
| 0.385 | 0.005 | 0.385 | M18 aspartyl aminopeptidase inhibitor | 0.137 0.059 CID_154699992 | ||
| 0.382 | 0.004 | 0.382 | Aldose reductase inhibitor | 0.306 0.004 CID_154699992 | ||
| 0.386 | 0.009 | 0.386 | Protein-tyrosine phosphatase inhibitor | 0.312 0.017 CID_154699992 | ||
| 0.381 | 0.016 | 0.381 | Dual specificity phosphatase 3 inhibitor | 0.143 0.102 CID_154699992 | ||
| 0.386 | 0.027 | 0.386 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.359 | 0.004 | 0.359 | Alpha tubulin antagonist | 0.073 0.023 CID_154699992 | ||
| 0.454 | 0.1 | 0.454 | DNA polymerase beta inhibitor | |||
| 0.351 | 0.003 | 0.351 | Multidrug resistance-associated protein 1 inhibitor | 0.298 0.004 CID_154699992 | ||
| 0.34 | 0.004 | 0.34 | Beta tubulin antagonist | 0.072 0.033 CID_154699992 | ||
| 0.336 | 0.003 | 0.336 | Carbonic anhydrase VII inhibitor | 0.213 0.004 CID_154699992 | ||
| 0.342 | 0.012 | 0.342 | Tumour necrosis factor antagonist | 0.135 0.12 CID_154699992 | ||
| 0.337 | 0.008 | 0.337 | Chelator | 0.164 0.031 CID_154699992 | ||
| 0.331 | 0.005 | 0.331 | Estrogen receptor beta antagonist | 0.103 0.059 CID_154699992 | ||
| 0.328 | 0.005 | 0.328 | Histidine decarboxylase inhibitor | |||
| 0.328 | 0.004 | 0.328 | Histone deacetylase stimulant | 0.284 0.004 CID_154699992 | ||
| 0.328 | 0.004 | 0.328 | Histone deacetylase SIRT1 stimulant | 0.284 0.004 CID_154699992 | ||
| 0.427 | 0.105 | 0.427 | DNA directed DNA polymerase inhibitor | |||
| 0.328 | 0.015 | 0.328 | Cholinergic | |||
| 0.349 | 0.037 | 0.349 | Dyrk kinase inhibitor | |||
| 0.347 | 0.035 | 0.347 | Transcription factor STAT inhibitor | |||
| 0.331 | 0.022 | 0.598 | Non-steroidal antiinflammatory agent | 0.598 0.004 CID_154699992 | CID_154699992 | |
| 0.312 | 0.005 | 0.312 | HIV-1 integrase (3'-Processing) inhibitor | 0.19 0.01 CID_154699992 | ||
| 0.311 | 0.005 | 0.693 | Cyclooxygenase 3 inhibitor | 0.693 0.002 CID_154699992 | CID_154699992 | |
| 0.307 | 0.006 | 0.307 | Estrogen antagonist | 0.133 0.035 CID_154699992 | ||
| 0.31 | 0.009 | 0.31 | Heat shock protein 90 antagonist | 0.137 0.089 CID_154699992 | ||
| 0.321 | 0.027 | 0.474 | Platelet adhesion inhibitor | 0.474 0.006 CID_154699992 | CID_154699992 | |
| 0.331 | 0.038 | 0.757 | Angiogenesis stimulant | 0.757 0.004 CID_154699992 | CID_154699992 | |
| 0.296 | 0.004 | 0.296 | Macrophage migration inhibitory factor inhibitor | |||
| 0.293 | 0.005 | 0.293 | HIV-1 integrase (Strand Transfer) inhibitor | 0.186 0.01 CID_154699992 | ||
| 0.299 | 0.011 | 0.299 | Protein-tyrosine phosphatase 1B inhibitor | 0.262 0.015 CID_154699992 | ||
| 0.304 | 0.016 | 0.304 | Amyloid beta precursor protein antagonist | 0.152 0.099 CID_154699992 | ||
| 0.292 | 0.005 | 0.292 | Protein kinase C zeta inhibitor | |||
| 0.304 | 0.017 | 0.322 | Neurotrophic factor enhancer | 0.322 0.013 CID_154699992 | CID_154699992 | |
| 0.282 | 0.005 | 0.658 | AMP-activated protein kinase stimulant | 0.658 0.002 CID_154699992 | CID_154699992 | |
| 0.277 | 0.003 | 0.288 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.288 0.003 CID_154699992 | CID_154699992 | |
| 0.29 | 0.019 | 0.29 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.272 | 0.002 | 0.272 | D-Ala-D-Ala ligase inhibitor | 0.088 0.049 CID_154699992 | ||
| 0.276 | 0.008 | 0.276 | Telomerase inhibitor | 0.103 0.032 CID_154699992 | ||
| 0.305 | 0.04 | 0.455 | Cyclic AMP phosphodiesterase inhibitor | 0.455 0.01 CID_154699992 | CID_154699992 | |
| 0.282 | 0.017 | 0.282 | Cytokine production inhibitor | |||
| 0.326 | 0.062 | 0.326 | 5 Hydroxytryptamine release stimulant | 0.197 0.124 CID_154699992 | ||
| 0.33 | 0.068 | 0.33 | Streptokinase A inhibitor | |||
| 0.275 | 0.015 | 0.275 | Succinate dehydrogenase inhibitor | 0.149 0.113 CID_154699992 | ||
| 0.268 | 0.014 | 0.334 | Topoisomerase I inhibitor | 0.334 0.009 CID_154699992 | CID_154699992 | |
| 0.342 | 0.091 | 0.521 | Immunosuppressant | 0.521 0.028 CID_154699992 | CID_154699992 | |
| 0.253 | 0.006 | 0.253 | Estrogen receptor alpha antagonist | |||
| 0.249 | 0.004 | 0.249 | DOPA decarboxylase inhibitor | 0.103 0.07 CID_154699992 | ||
| 0.249 | 0.004 | 0.249 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.258 | 0.014 | 0.258 | Butyrylcholinesterase inhibitor | |||
| 0.264 | 0.02 | 0.594 | Hemostatic | 0.594 0.004 CID_154699992 | CID_154699992 | |
| 0.29 | 0.05 | 0.29 | Interleukin antagonist | 0.16 0.111 CID_154699992 | ||
| 0.257 | 0.024 | 0.257 | Heat shock protein 90 alpha antagonist | |||
| 0.238 | 0.007 | 0.238 | Estrogen agonist | 0.127 0.013 CID_154699992 | ||
| 0.239 | 0.009 | 0.239 | Alcohol dehydrogenase inhibitor | 0.2 0.012 CID_154699992 | ||
| 0.246 | 0.016 | 0.246 | Protein kinase (CK2) alpha inhibitor | |||
| 0.235 | 0.012 | 0.235 | Toll-Like receptor 2 antagonist | 0.112 0.087 CID_154699992 | ||
| 0.245 | 0.022 | 0.245 | Cyclooxygenase 1 inhibitor | 0.178 0.044 CID_154699992 | ||
| 0.231 | 0.009 | 0.24 | Uric acid excretion stimulant | 0.24 0.008 CID_154699992 | CID_154699992 | |
| 0.246 | 0.026 | 0.246 | Bone formation stimulant | 0.178 0.042 CID_154699992 | ||
| 0.27 | 0.051 | 0.27 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.304 | 0.085 | 0.723 | Antithrombotic | 0.723 0.007 CID_154699992 | CID_154699992 | |
| 0.222 | 0.005 | 0.243 | Heat shock protein 70 antagonist | 0.243 0.004 CID_154699992 | CID_154699992 | |
| 0.219 | 0.006 | 0.219 | GABA C receptor rho-1 antagonist | |||
| 0.216 | 0.005 | 0.216 | Myeloperoxidase inhibitor | |||
| 0.245 | 0.038 | 0.245 | Mcl-1 antagonist | |||
| 0.216 | 0.01 | 0.318 | Photosensitizer | 0.318 0.004 CID_154699992 | CID_154699992 | |
| 0.21 | 0.009 | 0.21 | Urease inhibitor | |||
| 0.231 | 0.031 | 0.231 | Cyclooxygenase inhibitor | 0.172 0.055 CID_154699992 | ||
| 0.238 | 0.042 | 0.238 | Insulin sensitizer | 0.23 0.048 CID_154699992 | ||
| 0.203 | 0.008 | 0.203 | Electron transport complex I inhibitor | 0.131 0.035 CID_154699992 | ||
| 0.2 | 0.006 | 0.2 | Cyclin B3 inhibitor | |||
| 0.215 | 0.022 | 0.422 | Alkylator | 0.422 0.007 CID_154699992 | CID_154699992 | |
| 0.207 | 0.018 | 0.207 | CF transmembrane conductance regulator agonist | 0.159 0.061 CID_154699992 | ||
| 0.195 | 0.007 | 0.195 | CDC25A inhibitor | 0.103 0.026 CID_154699992 | ||
| 0.327 | 0.14 | 0.762 | Cyclophilin D inhibitor | 0.762 0.009 CID_154699992 | CID_154699992 | |
| 0.189 | 0.008 | 0.189 | Carbonic anhydrase V inhibitor | |||
| 0.192 | 0.012 | 0.192 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 CID_154699992 | ||
| 0.185 | 0.009 | 0.185 | Aromatase inhibitor | |||
| 0.18 | 0.004 | 0.18 | Fatty acid synthase inhibitor | 0.097 0.012 CID_154699992 | ||
| 0.202 | 0.027 | 0.202 | Aldehyde dehydrogenase inhibitor | 0.174 0.035 CID_154699992 | ||
| 0.182 | 0.01 | 0.182 | Keratolytic | |||
| 0.18 | 0.013 | 0.18 | Phosphodiesterase 4D inhibitor | |||
| 0.249 | 0.084 | 0.249 | Transcription factor STAT3 inhibitor | |||
| 0.197 | 0.032 | 0.197 | Cyclooxygenase 2 inhibitor | 0.145 0.057 CID_154699992 | ||
| 0.171 | 0.007 | 0.171 | Carbonic anhydrase VA inhibitor | |||
| 0.174 | 0.011 | 0.174 | Transcription factor STAT6 inhibitor | |||
| 0.27 | 0.109 | 0.376 | Angiogenesis inhibitor | 0.376 0.061 CID_154699992 | CID_154699992 | |
| 0.166 | 0.006 | 0.166 | Estrogen receptor beta agonist | 0.081 0.014 CID_154699992 | ||
| 0.193 | 0.034 | 0.21 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.025 CID_154699992 | CID_154699992 | |
| 0.175 | 0.019 | 0.175 | GABA C receptor antagonist | |||
| 0.266 | 0.113 | 0.266 | Thyroid hormone antagonist | |||
| 0.17 | 0.018 | 0.17 | Phosphodiesterase IV inhibitor | |||
| 0.194 | 0.044 | 0.273 | Interleukin 6 antagonist | 0.273 0.019 CID_154699992 | CID_154699992 | |
| 0.182 | 0.032 | 0.182 | Cholesterol synthesis inhibitor | 0.135 0.053 CID_154699992 | ||
| 0.162 | 0.014 | 0.176 | Thioredoxin inhibitor | 0.176 0.011 CID_154699992 | CID_154699992 | |
| 0.171 | 0.028 | 0.489 | Expectorant | 0.489 0.004 CID_154699992 | CID_154699992 | |
| 0.257 | 0.114 | 0.257 | Thyroid hormone beta antagonist | |||
| 0.152 | 0.009 | 0.152 | Thioredoxin reductase inhibitor | 0.097 0.032 CID_154699992 | ||
| 0.151 | 0.011 | 0.151 | Interleukin 5 antagonist | 0.131 0.017 CID_154699992 | ||
| 0.162 | 0.022 | 0.342 | DNA repair enzyme inhibitor | 0.342 0.004 CID_154699992 | CID_154699992 | |
| 0.144 | 0.009 | 0.144 | HIV-1 integrase inhibitor | 0.092 0.03 CID_154699992 | ||
| 0.202 | 0.067 | 0.202 | Histone acetyltransferase inhibitor | |||
| 0.161 | 0.028 | 0.161 | Protein kinase (CK2) inhibitor | |||
| 0.133 | 0.003 | 0.133 | Transcription factor RelA inhibitor | |||
| 0.14 | 0.011 | 0.162 | T cell inhibitor | 0.162 0.009 CID_154699992 | CID_154699992 | |
| 0.143 | 0.014 | 0.151 | Interleukin 12 antagonist | 0.151 0.012 CID_154699992 | CID_154699992 | |
| 0.133 | 0.005 | 0.283 | Carbonic anhydrase XIV inhibitor | 0.283 0.004 CID_154699992 | CID_154699992 | |
| 0.156 | 0.03 | 0.28 | Antineoplastic antibiotic | 0.28 0.011 CID_154699992 | CID_154699992 | |
| 0.138 | 0.012 | 0.138 | Lipase inhibitor | 0.106 0.024 CID_154699992 | ||
| 0.176 | 0.053 | 0.334 | Interferon gamma antagonist | 0.334 0.016 CID_154699992 | CID_154699992 | |
| 0.153 | 0.03 | 0.163 | Mucolytic | 0.163 0.026 CID_154699992 | CID_154699992 | |
| 0.164 | 0.042 | 0.181 | DNA polymerase I inhibitor | 0.181 0.035 CID_154699992 | CID_154699992 | |
| 0.175 | 0.056 | 0.175 | Neurotensin receptor agonist | |||
| 0.172 | 0.054 | 0.318 | Insulin secretagoues | 0.318 0.01 CID_154699992 | CID_154699992 | |
| 0.121 | 0.004 | 0.121 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.126 | 0.01 | 0.126 | CDC25B inhibitor | 0.063 0.047 CID_154699992 | ||
| 0.141 | 0.026 | 0.182 | Toll-Like receptor 4 antagonist | 0.182 0.009 CID_154699992 | CID_154699992 | |
| 0.119 | 0.004 | 0.119 | Catechol O-methyltransferase inhibitor | 0.031 0.026 CID_154699992 | ||
| 0.231 | 0.116 | 0.231 | Insulysin inhibitor | |||
| 0.221 | 0.109 | 0.516 | Immunostimulant | 0.516 0.027 CID_154699992 | CID_154699992 | |
| 0.144 | 0.031 | 0.398 | Mediator release inhibitor | 0.398 0.005 CID_154699992 | CID_154699992 | |
| 0.117 | 0.007 | 0.117 | Estrogen receptor alpha agonist | |||
| 0.206 | 0.096 | 0.206 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.152 | 0.044 | 0.152 | Antibacterial (Helicobacter pylori) | |||
| 0.154 | 0.048 | 0.154 | Farnesoid X receptor antagonist | |||
| 0.114 | 0.009 | 0.114 | Aryl hydrocarbon receptor antagonist | |||
| 0.17 | 0.065 | 0.17 | Arachidonic acid antagonist | |||
| 0.111 | 0.014 | 0.154 | Neuraminidase (influenza) inhibitor | 0.154 0.007 CID_154699992 | CID_154699992 | |
| 0.1 | 0.006 | 0.129 | Glucose-6-phosphate translocase inhibitor | 0.129 0.004 CID_154699992 | CID_154699992 | |
| 0.106 | 0.013 | 0.135 | Neuraminidase inhibitor | 0.135 0.008 CID_154699992 | CID_154699992 | |
| 0.21 | 0.12 | 0.21 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.151 | 0.061 | 0.151 | Adenylate cyclase stimulant | |||
| 0.125 | 0.038 | 0.125 | Sphingomyelinase inhibitor | 0.102 0.057 CID_154699992 | ||
| 0.128 | 0.04 | 0.128 | Bronchodilator | |||
| 0.101 | 0.014 | 0.101 | Protease activated receptor antagonist | |||
| 0.09 | 0.005 | 0.09 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.109 | 0.024 | 0.109 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.089 | 0.005 | 0.089 | Dopamine D5 agonist | |||
| 0.118 | 0.034 | 0.118 | Androgen antagonist | |||
| 0.283 | 0.2 | 0.283 | MAP kinase 1 inhibitor | |||
| 0.087 | 0.005 | 0.087 | GABA B receptor antagonist | |||
| 0.091 | 0.011 | 0.091 | Topoisomerase II beta inhibitor | 0.07 0.017 CID_154699992 | ||
| 0.229 | 0.151 | 0.229 | Sodium/bile acid cotransporter inhibitor | |||
| 0.096 | 0.018 | 0.096 | Maillard reaction inhibitor | 0.066 0.031 CID_154699992 | ||
| 0.224 | 0.149 | 0.224 | Vasodilator, peripheral | 0.2 0.176 CID_154699992 | ||
| 0.084 | 0.011 | 0.084 | CD45 antagonist | |||
| 0.08 | 0.009 | 0.08 | Ryanodine receptor antagonist | |||
| 0.108 | 0.036 | 0.108 | Ornithine decarboxylase inhibitor | 0.083 0.064 CID_154699992 | ||
| 0.149 | 0.079 | 0.288 | Hexokinase inhibitor | 0.288 0.012 CID_154699992 | CID_154699992 | |
| 0.096 | 0.026 | 0.096 | Dopamine D1 antagonist | |||
| 0.088 | 0.019 | 0.088 | Carbonic anhydrase VB inhibitor | |||
| 0.123 | 0.056 | 0.186 | DNA intercalator | 0.186 0.03 CID_154699992 | CID_154699992 | |
| 0.158 | 0.091 | 0.158 | Phospholipase C inhibitor | 0.14 0.129 CID_154699992 | ||
| 0.088 | 0.023 | 0.165 | Carbonic anhydrase XII inhibitor | 0.165 0.011 CID_154699992 | CID_154699992 | |
| 0.13 | 0.067 | 0.13 | Vanilloid 1 agonist | 0.121 0.085 CID_154699992 | ||
| 0.082 | 0.019 | 0.082 | Heat shock protein 90 beta antagonist | |||
| 0.109 | 0.046 | 0.109 | Prolactin inhibitor | |||
| 0.064 | 0.004 | 0.064 | Estrogen-related receptor beta antagonist | |||
| 0.091 | 0.031 | 0.091 | Leukotriene synthesis inhibitor | |||
| 0.073 | 0.014 | 0.073 | Potassium channel Kv1.3 blocker | |||
| 0.085 | 0.029 | 0.085 | Leukotriene antagonist | 0.081 0.031 CID_154699992 | ||
| 0.161 | 0.108 | 0.161 | I kappa B kinase epsilon inhibitor | |||
| 0.12 | 0.068 | 0.143 | Beta amyloid protein antagonist | 0.143 0.046 CID_154699992 | CID_154699992 | |
| 0.091 | 0.04 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_154699992 | CID_154699992 | |
| 0.076 | 0.025 | 0.076 | Cyclin B1 inhibitor | |||
| 0.071 | 0.021 | 0.071 | Cyclin B2 inhibitor | |||
| 0.059 | 0.011 | 0.102 | Arginase inhibitor | 0.102 0.004 CID_154699992 | CID_154699992 | |
| 0.074 | 0.026 | 0.074 | Protein kinase C eta inhibitor | |||
| 0.068 | 0.021 | 0.111 | Leukotriene B4 antagonist | 0.111 0.008 CID_154699992 | CID_154699992 | |
| 0.101 | 0.054 | 0.101 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.071 | 0.029 | 0.075 | Transcription factor AP-1 inhibitor | 0.075 0.025 CID_154699992 | CID_154699992 | |
| 0.081 | 0.039 | 0.088 | Phosphodiesterase VI inhibitor | 0.088 0.031 CID_154699992 | CID_154699992 | |
| 0.101 | 0.061 | 0.101 | Anabolic | |||
| 0.109 | 0.072 | 0.109 | TRPA1 agonist | |||
| 0.133 | 0.096 | 0.133 | Phospholipase A2 inhibitor | |||
| 0.15 | 0.116 | 0.153 | Psychostimulant | 0.153 0.114 CID_154699992 | CID_154699992 | |
| 0.044 | 0.01 | 0.044 | ATP citrate lysase inhibitor | |||
| 0.148 | 0.116 | 0.148 | Anesthetic general | 0.138 0.128 CID_154699992 | ||
| 0.057 | 0.027 | 0.057 | Vanilloid 2 antagonist | |||
| 0.061 | 0.031 | 0.061 | Cyclin B inhibitor | |||
| 0.092 | 0.062 | 0.092 | ABCA1 expression enhancer | |||
| 0.098 | 0.068 | 0.098 | Alpha 2c adrenoreceptor antagonist | |||
| 0.085 | 0.056 | 0.085 | mTOR complex 2 inhibitor | |||
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | |||
| 0.04 | 0.012 | 0.04 | Protein kinase (CK2) beta inhibitor | |||
| 0.076 | 0.048 | 0.076 | Glutamate decarboxylase inhibitor | |||
| 0.106 | 0.079 | 0.106 | Proteasome inhibitor | |||
| 0.141 | 0.118 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.105 | 0.082 | 0.134 | Microtubule formation inhibitor | 0.134 0.048 CID_154699992 | CID_154699992 | |
| 0.04 | 0.017 | 0.04 | Estrogen-related receptor alpha antagonist | |||
| 0.102 | 0.081 | 0.102 | Nav1.5 sodium channel blocker | |||
| 0.067 | 0.046 | 0.067 | Dopamine agonist | |||
| 0.113 | 0.093 | 0.113 | Toll-Like receptor 9 antagonist | |||
| 0.139 | 0.122 | 0.262 | ATPase inhibitor | 0.262 0.011 CID_154699992 | CID_154699992 | |
| 0.027 | 0.011 | 0.036 | Dopamine D1 agonist | 0.036 0.006 CID_154699992 | CID_154699992 | |
| 0.091 | 0.074 | 0.091 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.027 | 0.012 | 0.027 | Estrone sulfatase inhibitor | |||
| 0.078 | 0.064 | 0.078 | Glutathione S-transferase inhibitor | |||
| 0.05 | 0.037 | 0.05 | CXC chemokine 1 receptor antagonist | |||
| 0.235 | 0.222 | 0.235 | Calcium channel L-type activator | |||
| 0.062 | 0.049 | 0.062 | Beta 3 adrenoreceptor antagonist | |||
| 0.058 | 0.047 | 0.058 | Cyclin D1 inhibitor | |||
| 0.044 | 0.034 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CID_154699992 | CID_154699992 | |
| 0.08 | 0.07 | 0.08 | Vanilloid agonist | |||
| 0.041 | 0.032 | 0.041 | DNA gyrase subunit A inhibitor | |||
| 0.032 | 0.023 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.13 | 0.122 | 0.13 | Ca2+-transporting ATPase inhibitor | |||
| 0.05 | 0.043 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.05 | 0.045 | 0.05 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.215 | 0.213 | 0.215 | Transcription factor inhibitor | |||
| 0.067 | 0.065 | 0.067 | Adenosine A3 receptor antagonist | |||
| 0.046 | 0.044 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.016 | 0.022 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CID_154699992 | CID_154699992 | |
| 0.018 | 0.024 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 CID_154699992 | CID_154699992 | |
| 0.073 | 0.092 | 0.125 | NADH dehydrogenase inhibitor | 0.125 0.026 CID_154699992 | CID_154699992 | |
| 0.073 | 0.097 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 CID_154699992 | CID_154699992 | |
| 0.048 | 0.073 | 0.078 | Nitric oxide donor | 0.078 0.024 CID_154699992 | CID_154699992 | |
| 0.042 | 0.067 | 0.053 | Factor III inhibitor | 0.053 0.027 CID_154699992 | CID_154699992 | |
| 0.015 | 0.042 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.006 CID_154699992 | CID_154699992 | |
| 0.079 | 0.114 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 CID_154699992 | CID_154699992 | |
| 0.016 | 0.051 | 0.08 | Sodium/glucose cotransporter 2 inhibitor | 0.08 0.004 CID_154699992 | CID_154699992 | |
| 0.016 | 0.065 | 0.062 | Sodium/glucose cotransporter inhibitor | 0.062 0.004 CID_154699992 | CID_154699992 | |
| 0.091 | 0.146 | 0.303 | Thrombolytic | 0.303 0.023 CID_154699992 | CID_154699992 | |
| 0.148 | 0.208 | 0.281 | DNA synthesis inhibitor | 0.281 0.051 CID_154699992 | CID_154699992 | |
| 0.154 | 0.216 | 0.356 | Cholesterol antagonist | 0.356 0.062 CID_154699992 | CID_154699992 | |
| 0.045 | 0.109 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 CID_154699992 | CID_154699992 | |
| 0.056 | 0.125 | 0.097 | Falcipain 2 inhibitor | 0.097 0.054 CID_154699992 | CID_154699992 | |
| 0.062 | 0.132 | 0.13 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 CID_154699992 | CID_154699992 | |
| 0.057 | 0.13 | 0.098 | Falcipain inhibitor | 0.098 0.056 CID_154699992 | CID_154699992 | |
| 0.071 | 0.162 | 0.115 | Alpha-N-acetylglucosaminidase inhibitor | 0.115 0.083 CID_154699992 | CID_154699992 | |
| 0.031 | 0.129 | 0.096 | Heparanase inhibitor | 0.096 0.004 CID_154699992 | CID_154699992 | |
| 0.023 | 0.133 | 0.043 | Microtubule stabilization | 0.043 0.038 CID_154699992 | CID_154699992 | |
| 0.026 | 0.138 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.053 CID_154699992 | CID_154699992 | |
| 0.02 | 0.133 | 0.069 | Antibiotic Aminoglycoside-like | 0.069 0.006 CID_154699992 | CID_154699992 | |
| 0.103 | 0.216 | 0.298 | Platelet antagonist | 0.298 0.053 CID_154699992 | CID_154699992 | |
| 0.08 | 0.194 | 0.232 | Cell wall synthesis inhibitor | 0.232 0.02 CID_154699992 | CID_154699992 | |
| 0.053 | 0.17 | 0.087 | Triose-phosphate isomerase inhibitor | 0.087 0.064 CID_154699992 | CID_154699992 | |
| 0.129 | 0.263 | 0.36 | Peptidyltransferase inhibitor | 0.36 0.011 CID_154699992 | CID_154699992 | |
| 0.036 | 0.179 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.029 CID_154699992 | CID_154699992 | |
| 0.052 | 0.205 | 0.125 | Transcription factor NF kappa B stimulant | 0.125 0.023 CID_154699992 | CID_154699992 | |
| 0.016 | 0.174 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_154699992 | CID_154699992 | |
| 0.02 | 0.185 | 0.331 | Selectin antagonist | 0.331 0.004 CID_154699992 | CID_154699992 | |
| 0.067 | 0.242 | 0.154 | Diuretic | 0.154 0.074 CID_154699992 | CID_154699992 | |
| 0.018 | 0.199 | 0.092 | Protein 50S ribosomal subunit inhibitor | 0.092 0.015 CID_154699992 | CID_154699992 | |
| 0.064 | 0.298 | 0.204 | Interleukin agonist | 0.204 0.117 CID_154699992 | CID_154699992 | |
| 0.05 | 0.349 | 0.219 | Hypolipemic | 0.219 0.083 CID_154699992 | CID_154699992 | |
| 0.088 | 0.423 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.052 CID_154699992 | CID_154699992 | |
| 0.036 | 0.416 | 0.193 | Cell adhesion inhibitor | 0.193 0.027 CID_154699992 | CID_154699992 | |
| 0.078 | 0.606 | 0.349 | Interleukin 2 agonist | 0.349 0.046 CID_154699992 | CID_154699992 | |
| 0.038 | 0.656 | 0.306 | Immunomodulator | 0.306 0.079 CID_154699992 | CID_154699992 | |
| 0.008 | 0.738 | 0.143 | Anticoagulant | 0.143 0.087 CID_154699992 | CID_154699992 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |